Literature DB >> 8063378

Transforming growth factor beta 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages.

E H Hausmann1, S Y Hao, J L Pace, M J Parmely.   

Abstract

Bacterial lipopolysaccharides (LPS) are potent inducers of macrophage activation, leading to the production of a number of proinflammatory mediators. Although several cytokines that prime macrophages for enhanced LPS-triggered responses have been identified, far less is known regarding the role that cytokines play in down-regulating macrophage responses to LPS. This study was designed to determine the effects of recombinant transforming growth factor beta 1 (rTGF-beta 1) on macrophage activation by LPS. Pretreatment of either mouse peritoneal macrophages or cells of the RAW 264.7 macrophage-like cell line with rTGF-beta 1 inhibited their ability to produce both tumor necrosis factor alpha (TNF-alpha) and nitric oxide (NO) in response to LPS. These inhibitory effects were reversed by increasing the concentration of LPS or by priming cells with optimal concentrations of recombinant gamma interferon (rIFN-gamma). Pretreatment of cells with rTGF-beta 1 had only a modest inhibitory effect on the expression of TNF-alpha mRNA. By contrast, the expression of mRNA for the inducible form of nitric oxide synthase (iNOS), which is responsible for NO production in activated macrophages, was significantly inhibited by rTGF-beta 1 pretreatment. Thus, rTGF-beta 1-dependent suppression of macrophage TNF-alpha biosynthesis was manifest at a posttranscriptional level, whereas the inhibition of NO production correlated with a direct effect on iNOS gene expression. Importantly, both of these suppressive effects of rTGF-beta 1 were reversed by exposing the cells to priming concentrations of rIFN-gamma. As with NO production, immunocytochemical analysis of iNOS expression in LPS-stimulated macrophages revealed that rIFN-gamma and rTGF-beta 1 had antagonistic effects, with the former increasing, and the latter reducing, the number of iNOS-expressing cells induced by LPS. These data suggest that a balance between the priming effects of IFN-gamma and the inhibitory effects of TGF-beta 1 can determine the overall level of macrophage activation induced by LPS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063378      PMCID: PMC303011          DOI: 10.1128/iai.62.9.3625-3632.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.

Authors:  R Kamijo; K Takeda; M Nagumo; K Konno
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Comparison of transforming growth factor-beta and a macrophage- deactivating polypeptide from tumor cells. Differences in antigenicity and mechanism of action.

Authors:  S Tsunawaki; M Sporn; C Nathan
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

4.  Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.

Authors:  A Ding; C F Nathan; J Graycar; R Derynck; D J Stuehr; S Srimal
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  Deactivation of macrophages by transforming growth factor-beta.

Authors:  S Tsunawaki; M Sporn; A Ding; C Nathan
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

7.  Modulation of cytokine production by transforming growth factor-beta.

Authors:  D Chantry; M Turner; E Abney; M Feldmann
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

Review 8.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

9.  Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.

Authors:  T Espevik; I S Figari; M R Shalaby; G A Lackides; G D Lewis; H M Shepard; M A Palladino
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

10.  Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

Authors:  G E Ranges; I S Figari; T Espevik; M A Palladino
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  6 in total

1.  Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta1 in tumor cells. Implications for tumor development.

Authors:  P Lagadec; S Raynal; B Lieubeau; N Onier; L Arnould; V Saint-Giorgio; D A Lawrence; J F Jeannin
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6.

Authors:  R E Lyons; J P Anthony; D J Ferguson; N Byrne; J Alexander; F Roberts; C W Roberts
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.

Authors:  F Obermeier; G Kojouharoff; W Hans; J Schölmerich; V Gross; W Falk
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 4.  Possible Treatment Approaches of Sulfur Mustard-Induced Lung Disorders, Experimental and Clinical Evidence, an Updated Review.

Authors:  Mohammad Reza Khazdair; Mohammad Hossein Boskabady
Journal:  Front Med (Lausanne)       Date:  2022-04-29

5.  TGF-β Signalling Mediates the Anti-Inflammatory Activity of Enamel Matrix Derivative In Vitro.

Authors:  Layla Panahipour; Mariane Beatriz Sordi; Zahra Kargarpour; Reinhard Gruber
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

6.  Flexibilide obtained from cultured soft coral has anti-neuroinflammatory and analgesic effects through the upregulation of spinal transforming growth factor-β1 in neuropathic rats.

Authors:  Nan-Fu Chen; Shi-Ying Huang; Ching-Hsiang Lu; Chun-Lin Chen; Chien-Wei Feng; Chun-Hong Chen; Han-Chun Hung; Yen-You Lin; Ping-Jyun Sung; Chun-Sung Sung; San-Nan Yang; Hui-Min David Wang; Yu-Chia Chang; Jyh-Horng Sheu; Wu-Fu Chen; Zhi-Hong Wen
Journal:  Mar Drugs       Date:  2014-06-27       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.